Patterns of use of sildenafil among commercially insured adults in the United States: 1998–2002
Authors:
- 19 February 2004
- journal article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 16 (4) , 313-318
Abstract
Sildenafil is increasingly being marketed to younger healthcare consumers. The purpose of this study was to profile sildenafil use in commercially insured, adult beneficiaries. Annual ambulatory prescription claims data from 1998 to 2002, for a nationwide, random sample of over 5 million life-years of commercially insured adults (aged 18 y), were examined retrospectively. The overall prevalence of sildenafil use increased from 0.8% (1998) to 1.4% (2002), an 84% increase. While the growth in use slowed in older males, use became more pronounced in younger males and females and decreased in older females. The fastest growing segment of users was found to be males aged 18–45 y. The proportion of users who had two or more claims for a medication that is suspected of inducing erectile dysfunction (ED) and/or a marker for a suspected ED-inducing disease decreased over the study period. Our findings suggest that use may increase among younger male and female patients and those without an underlying etiologic reason for use.Keywords
This publication has 30 references indexed in Scilit:
- Viagra: A Success Story For Rationing?Health Affairs, 2002
- Myocardial infarction following the combined recreational use of viagra® and cannabisClinical Cardiology, 2002
- ‘Viagra® Effect’ – Influence of Mass Media on Patient BehaviorUrologia Internationalis, 2001
- The Economics Of ViagraHealth Affairs, 2000
- Erectile dysfunction in general medicine practice: prevalence and clinical correlatesInternational Journal Of Impotence Research, 2000
- DiscussionThe American Journal of Cardiology, 1999
- Comparative Results of Goal Oriented Therapy for Erectile DysfunctionJournal of Urology, 1997
- Outcome Analysis of Goal Directed Therapy for ImpotenceJournal of Urology, 1996
- NIH Consensus Conference. Impotence. NIH Consensus Development Panel on ImpotenceJAMA, 1993
- Physician motivations for nonscientific drug prescribingSocial Science & Medicine, 1989